125 completed, 25 unknown, 2 not yet recruiting, 2 recruiting. 156 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 156 | Completed 125, Unknown 25, Not yet recruiting 2, Recruiting 2, Withdrawn 2 |
Follow Bioequivalence: new trials by email Literature Review of Bioequivalence trials Research Report on Bioequivalence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Pharmacokinetics of UI112 Compared With UIC202611 in Healthy Adults Semaglutide (UI112), Semaglutide (UIC202611) - Bioequivalence, Pharmacokinetics | Phase 1 | Not yet recruiting | Korea United Pharm. Inc. | 44 | 2027-01-01 | 2026-11-13 |
| A Randomized, Double-Blind, Positive-Controlled, Parallel Pharmacokinetic Phase I Clinical Study of Cetuximab Injection Versus Erbitux in Healthy Male Subjects HC034S, Erbitux (Cetuximab) - Cetuximab, Bioequivalence | Phase 1 | Recruiting | HC Biopharma Inc. | 92 | 2026-09-12 | 2026-11-04 |
| An Open-label, Randomized, Single Oral Dose, Two-period, Two-sequence, Two-way, Crossover Bioequivalence Study on Healthy Adult Male Participants Under Fed Conditions to Compare, Test Product Palbociclib-EVAPHARMA 125 mg Hard Gelatin Capsule, Versus the Reference Product Ibrance™125 mg Capsules Palbociclib-EVAPHARMA 125 mg Hard Gelatin Capsule, Ibrance capsules - Bioequivalence, Male | Phase 1 | Completed | Zi Diligence Biocenter | 30 | 2026-02-09 | 2026-11-06 |
| A Bioequivalence Study of Advil Tablet (Mini) (Ibuprofen 200 mg) Versus Advil Tablet (Ibuprofen 200 mg) in Healthy Adult Subjects Under Fasted Conditions and Bioavailability Assessment of Advil Tablet (Mini) Under Fed Conditions Advil Tablet (Mini) (Test Product), Advil Tablet (Reference Product) - Bioequivalence, Bioavailability | Phase 1 | Completed | HALEON | 68 | 2025-12-17 | 2026-09-23 |
| Bioequivalence Study of Levetiracetam 1500 mg Coated Granules in Healthy, Male Subjects Levetiracetam 1500 mg, Keppra® 750 mg - Pharmacokinetic Analysis, Bioequivalence | Phase 1 | Completed | Desitin Arzneimittel GmbH | 20 | 2025-12-17 | 2026-02-06 |
| Bioequivalence and Adhesion of a Rotigotine Patch in Healthy Subjects Rotigotine Transdermal Delivery System (TDS) - Bioequivalence, Adhesion | Phase 1 | Completed | Amarin Technologies S.A.U. | 35 | 2025-12-04 | 2026-08-19 |
| Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects Under Fed Conditions RLF-OD032 100 mg/mL oral suspension, Kuvan 100 MG Powder for Oral Solution - Bioequivalence | Phase 1 | Completed | APR Applied Pharma Research s.a. | 42 | 2025-08-20 | 2026-04-28 |
| Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast Cancer Patients Paclitaxel protein-bound particles for injectable suspension (albumin-bound), Abraxane® - Bioequivalence | Phase 1 | Recruiting | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 28 | 2025-06-26 | 2025-07-31 |
| A Study to Learn if There is a Difference in the Blood Levels of Acetylsalicylic Acid When Taken as Different Chewable Tablets on an Empty Stomach by Healthy Participants Acetylsalicylic Acid (Aspirin, BAYE004465, UI1610477), Acetylsalicylic Acid (BAYE004465, UI1615160) - Bioequivalence, Healthy Volunteers | Phase 1 | Completed | Bayer | 38 | 2025-02-26 | 2025-04-15 |
| Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants Group A, Reference Group - Bioequivalence | Phase 1 | Not yet recruiting | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 110 | 2025-02-01 | 2025-02-17 |
| Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions Perindopril tablet, Prestarium® A tablet - Bioequivalence | Phase 1 | Unknown | Pharmtechnology LLC | 50 | 2024-01-09 | 2024-01-19 |
| Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273 ZSP1273 tablet, zsp1273 granules - Bioequivalence | Phase 1 | Completed | Guangdong Raynovent Biotech Co., Ltd | 32 | 2023-11-23 | 2024-01-29 |
| Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd. - Bioequivalence, Schizophrenia | Phase 1 | Unknown | The Affiliated Hospital of Qingdao University | 100 | 2023-09-20 | 2023-10-04 |
| Bioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS® 500/50 - Bioequivalence | Phase 1 | Unknown | Respirent Pharmaceuticals Co Ltd. | 34 | 2023-08-22 | 2023-09-06 |
| Bioequivalence Study for Fluticasone Propionate 250 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS® 250/50 - Bioequivalence | Phase 1 | Unknown | Respirent Pharmaceuticals Co Ltd. | 34 | 2023-08-01 | 2023-08-31 |
| Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®. GP40221, ozempic - Pharmacokinetics, Safety Issues | Phase 1 | Completed | Geropharm | 120 | 2023-06-30 | 2024-07-11 |
| Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg tablet - Bioequivalence | Phase 1 | Unknown | Pharmtechnology LLC | 50 | 2023-06-24 | 2023-07-11 |
| Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions Clopidogrel film-coated tablet 75 mg, Plavix® film-coated tablet 75 mg - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 60 | 2023-06-16 | 2023-11-30 |
| Bioequivalence of Amphotericin B Liposome for Injection Amphotericin B liposome for injection, AmBisome - Bioequivalence | Phase 1 | Completed | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 32 | 2023-06-02 | 2023-09-28 |
| Rivastigmine Bioequivalence Trial With Multiple Applications of Transdermal Patches (9.5 mg/24 h) Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h - Bioequivalence | Phase 1 | Completed | SocraTec R&D GmbH | 38 | 2023-04-17 | 2024-02-02 |
Showing 20 of 156. Sign in to see all of them.
Diabetes Mellitus, Type 2 (7) · Asthma (4) · Fasting (3) · Lecithin Cholesterol Acyltransferase Deficiency (2) · COVID-19 (1) · Graves Ophthalmopathy (1) · Multiple Myeloma (1) · Schizophrenia (1) · Tissue Adhesions (1)
Metabolic Diseases (9) · Nutritional and Metabolic Diseases (9) · Endocrine System Diseases (8) · Diabetes Mellitus (7) · Glucose Metabolism Disorders (7) · Immune System Diseases (6) · Lung Diseases (5) · Respiratory Tract Diseases (5) · Bronchial Diseases (4) · Hypersensitivity (4) · Hypersensitivity, Immediate (4) · Lung Diseases, Obstructive (4) · Respiratory Hypersensitivity (4) · Behavior (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)
Fluticasone (16) · Salmeterol Xinafoate (14) · Drug Evaluation (13) · Metformin (9) · Tablets (7) · Patents as Topic (6) · Sitagliptin Phosphate (6) · Ethinyl Estradiol (5) · Motion Pictures (5) · favipiravir (5) · Amlodipine (3) · Fluconazole (3) · Indapamide (3) · Powders (3) · Rivastigmine (3)
Pharmtechnology LLC (23) · Respirent Pharmaceuticals Co Ltd. (16) · Laboratorios Andromaco S.A. (14) · Galenicum Health (6) · Darnitsa Pharmaceutical Company (5) · Geropharm (5) · SocraTec R&D GmbH (5) · AstraZeneca (4) · Pfizer (4) · Alembic Pharmaceuticals Ltd. (3) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (3) · Abbott (2) · Atabay Kimya Sanayi Ticaret A.S. (2) · Bayer (2) · Cinnagen (2)
Russia (21) · Greece (16) · Canada (15) · China (15) · United States (14) · Chile (9) · Turkey (Türkiye) (9) · India (7) · Mexico (6) · Germany (5) · United Kingdom (5) · Egypt (4) · Jordan (4) · Pakistan (4) · South Korea (3)
Eric Sicard, MD (9) · Ioannis Stefanidis, Professor (9) · Muradiye Nacak, MD,PhD (8) · Alexander Khokhlov (6) · Chrysoula Doxani, MD, MSc, PhD (6) · Taner Ezgi, MD (5) · Alexander Khokhlov, Professor (2) · Cornelius Koch, MD (2) · Eric Sicard (2) · Irina Rodyukova (2) · Sergey Filatov (2) · Anastasia Teteryukova, MD (1) · Anna Chan (1)
PMID 36526947, PMID 10870982, PMID 17412566, PMID 17683253, PMID 18589125, PMID 19806435, PMID 20681586, PMID 21714845, PMID 21843564, PMID 22068541, PMID 23574401, PMID 24378755, PMID 26621118, PMID 31420787, PMID 31985294, PMID 35034311, PMID 35696054, PMID 37036155, PMID 37740581, PMID 39414078, PMID 41293254, PMID 42678488
2016 (2), 2018 (2), 2008 (1), 2023 (1)